GI
TEVA icon

GAMCO Investors’s Teva Pharmaceuticals TEVA Stock Holding History

GAMCO Investors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.24M Hold
66,100
– – 0.02% 484
2026
Q1 		$1.99M Sell
66,100
-21,100
-24% -$679K 0.02% 519
2025
Q4 		$2.72M Sell
87,200
-2,000
-2% -$49.3K 0.03% 479
2025
Q3 		$1.8M Hold
89,200
– – 0.02% 547
2025
Q2 		$1.49M Sell
89,200
-4,000
-4% -$64.5K 0.01% 593
2025
Q1 		$1.43M Sell
93,200
-12,400
-12% -$221K 0.02% 530
2024
Q4 		$2.33M Sell
105,600
-24,100
-19% -$438K 0.02% 479
2024
Q3 		$2.34M Sell
129,700
-4,550
-3% -$79.6K 0.02% 483
2024
Q2 		$2.18M Sell
134,250
-10,800
-7% -$166K 0.02% 482
2024
Q1 		$2.05M Sell
145,050
-2,750
-2% -$34.7K 0.02% 492
2023
Q4 		$1.54M Hold
147,800
– – 0.02% 527
2023
Q3 		$1.51M Sell
147,800
-600
-0.4% -$5.59K 0.02% 524
2023
Q2 		$1.12M Sell
148,400
-4,000
-3% -$32.4K 0.01% 562
2023
Q1 		$1.35M Sell
152,400
-4,400
-3% -$43.5K 0.01% 541
2022
Q4 		$1.43M Sell
156,800
-1,600
-1% -$14K 0.02% 530
2022
Q3 		$1.28M Sell
158,400
-17,500
-10% -$155K 0.02% 533
2022
Q2 		$1.32M Sell
175,900
-12,200
-6% -$106K 0.01% 535
2022
Q1 		$1.77M Buy
188,100
+500
+0.3% +$4.17K 0.02% 526
2021
Q4 		$1.5M Sell
187,600
-10,000
-5% -$90.3K 0.01% 553
2021
Q3 		$1.93M Hold
197,600
– – 0.02% 515
2021
Q2 		$1.96M Buy
197,600
+29,200
+17% +$309K 0.02% 528
2021
Q1 		$1.94M Buy
+168,400
New +$1.93M 0.02% 515

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

GAMCO Investors's TEVA Position: Q2 2026 in Review

GAMCO Investors held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 66,100 shares worth $2.24M. The position accounts for 0.02% of the portfolio, ranked #484.

GAMCO Investors first reported a position in TEVA in Q1 2021 and has held it in 22 quarters since. The position peaked at $2.72M in Q4 2025. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • GAMCO Investors held 66,100 shares of Teva Pharmaceuticals worth $2.24M as of Q2 2026.
  • GAMCO Investors left its Teva Pharmaceuticals share count unchanged in Q2 2026.
  • Teva Pharmaceuticals made up 0.02% of GAMCO Investors's portfolio in Q2 2026, its #484 holding.
  • GAMCO Investors first reported a position in Teva Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • GAMCO Investors's Teva Pharmaceuticals position peaked at $2.72M in Q4 2025.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on GAMCO Investors's 13F filing for Q2 2026, filed 12 Aug 2026.